Ultragenyx Pharmaceutical Inc. (RARE) is a publicly traded Healthcare sector company. As of May 21, 2026, RARE trades at $24.00 with a market cap of $2.38B and a P/E ratio of -3.82. RARE moved +4.14% today. Year to date, RARE is +1.13%; over the trailing twelve months it is -37.43%. Its 52-week range spans $18.29 to $58.00. Analyst consensus is strong buy with an average price target of $48.86. Rallies surfaces RARE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Ultragenyx Pharmaceutical Inc. (RARE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RARE moved +4.14% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $24.00 |
| Market Cap | $2.38B |
| P/E Ratio | -3.82 |
| EPS | $-6.10 |
| Dividend Yield | 0.00% |
| 52-Week High | $58.00 |
| 52-Week Low | $18.29 |
| Volume | 1.25M |
| Avg Volume | 0 |
| Revenue (TTM) | $669.71M |
| Net Income | $-608.92M |
| Gross Margin | 0.00% |
15 analysts cover RARE: 0 strong buy, 13 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $48.86.